Emerging Gene Therapies Bitesize – Session 1
Reverse Rett CEO Rachael Stevenson with an introduction to gene therapy in Rett syndrome and the programs currently in clinical trials
Emerging Gene Therapies Bitesize – Session 2
Reverse Rett CEO Rachael Stevenson expanding on understanding the clinical trial process, selection and inclusion and exclusion criteria
Emerging Gene Therapies Bitesize – Session 3
Dr Dan Lumsden, Rett service lead at the Evelina Children’s Hospital provides an update on the latest Rett gene therapy news and answers questions from the community.
As always, thank you to everyone supporting the work of Reverse Rett, whether through fundraising, sharing on social media or helping us develop critical regulatory resources reflecting the patient experience of Rett. We can’t do any of it without you.